FDA

FDA Misses Deadline for Novavax COVID-19 Vaccine Decision

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has missed its April 1 deadline to decide on the full approval of Novavax's COVID-19 vaccine, NVX-CoV2373. This delay follows...

Postidal Shopping

spot_img

Follow us

HomeFDA